Publicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (92)

2022

  1. A Multicenter Study of 2-year Outcomes Following Hyperthermia Therapy with Mitomycin C in Treating Non-Muscle Invasive Bladder Cancer: HIVEC-E

    Bladder Cancer, Vol. 8, Núm. 4, pp. 379-393

  2. Approach to Lower Urinary Tract Reconstruction: A Survey of Adult and Pediatric Urologist Perspectives and Experiences

    Frontiers in Urology, Vol. 2

  3. BlaDimiR: A Urine-based miRNA Score for Accurate Bladder Cancer Diagnosis and Follow-up

    European Urology

  4. Corrigendum to <‘Mitomycin C allergy after passive and device-assisted hyperthermia for non-muscle invasive bladder cancer treatment: A retrospective cohort from a high-volume center’> <[Volume 40, Issue 7, July 2022, Pages 345.e19-345.e23]> (Urologic Oncology: Seminars and Original Investigations (2022) 40(7) (345.e19–345.e23), (S1078143922000679), (10.1016/j.urolonc.2022.02.018))

    Urologic Oncology: Seminars and Original Investigations

  5. Metastatic testicular cancer presenting with hematuria and flank pain

    Urology Annals, Vol. 14, Núm. 2, pp. 196-198

  6. Mitomycin C allergy after passive and device-assisted hyperthermia for non-muscle invasive bladder cancer treatment: A retrospective cohort from a high-volume center

    Urologic Oncology: Seminars and Original Investigations, Vol. 40, Núm. 7, pp. 345.e19-345.e23

  7. Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trial

    World Journal of Urology, Vol. 40, Núm. 4, pp. 999-1004

2021

  1. Analgesic refractory colic pain: Is prolonged conservative management appropriate?

    American Journal of Emergency Medicine, Vol. 44, pp. 137-142

  2. Evaluation of health care-associated infections following radical cystectomy

    Actas Urologicas Espanolas, Vol. 45, Núm. 2, pp. 124-131

  3. Incontinent Urinary Diversion

    Bladder Cancer: A Practical Guide (Springer International Publishing), pp. 205-217

  4. Long surgical waiting list times are associated with an increased rate of negative ureteroscopies

    Canadian Urological Association Journal, Vol. 15, Núm. 12

  5. Quality of life and adverse events in patients with nonmuscle invasive bladder cancer receiving adjuvant treatment with BCG, MMC, or chemohyperthermia

    Urologic Oncology: Seminars and Original Investigations, Vol. 39, Núm. 1, pp. 76.e9-76.e14